12:00 AM
 | 
Nov 15, 2010
 |  BC Week In Review  |  Company News  |  Deals

Aires, Novartis deal

Aires granted Novartis an option to acquire the company after completion of a Phase II trial of Aires' Aironite to treat pulmonary arterial hypertension (PAH). The trial...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >